Emerging potential value of long non-coding RNAs as biomarkers and therapeutic targets in pancreatic cancer
Year: 2024
Type: article
Abstract: : Pancreatic cancer (PC) is often asymptomatic in its early stages and is usually diagnosed late and in advanced stages, which can make treatment difficult and usually patients do not have a good prognosis, so early diagnosis of this disease is very important. Long non-coding RNAs (lncRNAs) have been shown to play an important role in the proliferation of cancer cells, metastasis and invasion. The lncRNAs are predicted to have a wide range of functions in cellular processes, and may be useful as biomarkers for early detection and therapeutic target in treatment of PC. The recent application of next-generation sequencing has nowadays provided a novel inside on gene profiling in multiple tumors and revealed the potential value of aberrant expression of lncRNAs with PC. In this study, 160 articles were reviewed, and lncRNAs associated with PC diagnosis, prognosis, and treatment were identified independently. Furthermore, the levels of expression of various lncRNAs in PC as well as the effective molecular pathways were described and discussed. This study hopes to help researchers identify lncRNAs that can be used as biomarkers for diagnostic and prognostic purposes, as well as discover the details of the cellular mechanisms underlying these lncRNAs in order to develop treatments that can be taken advantage of.
Source: Annals of Pancreatic Cancer
DOI: 10.21037/apc-23-17
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4396242569
